National Institute on Drug Abuse: Behavioral Pharmacology and Genetics Research Grant (R03)

Opportunity ID: 42946

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-09-016
Funding Opportunity Title: Behavioral Pharmacology and Genetics: Translating and Targeting Individual Differences (R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 01, 2008
Last Updated Date:
Original Closing Date for Applications: Jan 27, 2009
Current Closing Date for Applications: Jan 27, 2009
Archive Date: Feb 27, 2009
Estimated Total Program Funding: $2,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Independent school districts
City or township governments
State governments
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: -Purpose. Individual differences in response to drugs of abuse may confer vulnerability or resistance to drug abuse or the development of addiction. Several lines of evidence indicate that genetic variation contributes to drug abuse and addiction as well as to the propensity to use specific classes of drugs, such as psychostimulants, opiates, marijuana and nicotine. Recently developed genetic methodologies make it possible to better understand drug abuse phenotypes in terms of underlying genetic factors. This FOA seeks applications that use controlled, human laboratory-based experimental techniques for the measurement of behavior, combined with genetic analyses, to study drug abuse phenotypes and/or endophenotypes, and their relationship to (a) individual differences in response to drugs of abuse; (b) individual differences in the consequences of repeated abuse; or (c) pharmacogenetic differences in response to putative or currently used pharmacotherapeutic agents for treating addiction. Research in these areas may identify genetic variations that will help define the biochemical mechanisms underlying drug effects and the associated biological and/or behavioral processes responsible for individual differences, and may suggest genetically targeted pharmacotherapeutic approaches for treating addiction.
-Mechanism of Support. This FOA will utilize the R03 grant mechanism to support projects including pilot and feasibility studies; small, self-contained research projects; and to foster the establishment of new research collaborations between geneticists and drug abuse researchers. As the R03 is intended to support small research projects that can be carried out in a short period of time with limited resources, it is intended that, with the use of this mechanism, investigators and collaborative research groups will be able to conduct initial pilot and feasibility studies to better position them for a subsequent R01 application. 
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-016.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.279 ADOBE-FORMS-A Adobe-Forms-A PKG00009586 Dec 27, 2008 Jan 27, 2009 View

Package 1

Mandatory forms

42946 RR_SF424-1.1.pdf

42946 RR_KeyPersonExpanded-1.1.pdf

42946 RR_OtherProjectInfo-1.1.pdf

42946 RR_PerformanceSite-1.1.pdf

42946 PHS398_CoverPageSupplement-1.1.pdf

42946 PHS398_ResearchPlan-1.1.pdf

42946 PHS398_Checklist-1.1.pdf

Optional forms

42946 PHS398_CoverLetter-1.1.pdf

42946 PHS398_ModularBudget-1.1.pdf

42946 RR_Budget-1.1.pdf

42946 RR_SubawardBudget-1.2.pdf


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *